CYP3A and CYP2B6 Genotype Predicts Glucose Metabolism Disorder among HIV Patients on Long-Term Efavirenz-Based ART: A Case-Control Study

Long-term antiretroviral treatment (cART) increases the risk of glucose metabolism disorders (GMDs). Genetic variation in drug-metabolizing enzymes and transporters may influence susceptibility to cART-associated GMDs. We conducted a case-control study to investigate the association of pharmacogenet...

Descripción completa

Detalles Bibliográficos
Autores principales: Tadesse, Wondmagegn Tamiru, Mlugu, Eulambius Mathias, Shibeshi, Workineh, Degu, Wondwossen Amogne, Engidawork, Ephrem, Aklillu, Eleni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315529/
https://www.ncbi.nlm.nih.gov/pubmed/35887584
http://dx.doi.org/10.3390/jpm12071087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315529/
https://www.ncbi.nlm.nih.gov/pubmed/35887584
http://dx.doi.org/10.3390/jpm12071087

Ejemplares similares